
GC75619
HBV-IN-37
Also known as 2-[3-(4-chlorophenyl)-1-phenylpyrazol-4-yl]-3-(oxolan-2-ylmethyl)-1,3-thiazolidin-4-one
HBV-IN-37 is an inhibitor of HBV with an EC50 value of 10 μM
ChemicalCAS380483-01-2MW439.96FormulaC23H22ClN3O2S
- CAS number
- 380483-01-2
- Molecular weight
- 439.96
- Formula
- C23H22ClN3O2S
- Solubility
- DMSO: 16·67 mg/mL (37·89 mM; ultrasonic and warming and heat to 60°C)
- InChIKey
- HKUHKRJFLLZKRF-UHFFFAOYSA-N
- Catalogue number
- GC75619
- Brand
- GLPBIO
Computed properties PubChem CID 4373606 · XLogP 4.5 · TPSA 72.7 Ų · H-bond donors 0
- XLogP
- 4.5
- TPSA
- 72.7 Ų
- H-bond donors
- 0
- H-bond acceptors
- 4
- Rotatable bonds
- 5
- Heavy atoms
- 30
SMILES C1CC(OC1)CN2C(SCC2=O)C3=CN(N=C3C4=CC=C(C=C4)Cl)C5=CC=CC=C5
Computed descriptors from PubChem (CID 4373606), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il